SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549-1004 |
|
|
FORM 8-K |
CURRENT REPORT PURSUANT TO SECTION 13 OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
Date of Report (date of earliest event reported): March 8, 2002 |
|
CIPHERGEN BIOSYSTEMS, INC. |
(Exact name of Registrant as specified in its charter) |
Delaware |
|
000-31617 |
|
33-059-5156 |
(State or other jurisdiction of incorporation or organization) |
|
(Commission File No.) |
|
(I.R.S. Employer Identification Number) |
6611 Dumbarton Circle
Fremont, CA 94555
(Address of principal executive offices)
(510) 505-2100
(Registrants telephone number, including area code)
ITEM 5. OTHER EVENTS
On March 8, 2002, Ciphergen Biosystems, Inc. issued a press release announcing that the Board of Directors of Ciphergen approved the adoption of a Stockholder Rights Plan. The press release is attached as Exhibit 99.3 to this Form 8-K.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits.
Exhibit 99.3 Ciphergen Biosystems, Inc. Press Release issued March 8, 2002.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act or 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Ciphergen Biosystems, Inc. (Registrant) |
|
Date: March 8, 2002 |
|
|
|
By |
/s/ Matthew J. Hogan |
|
|
Matthew J. Hogan |
|
|
Chief Financial Officer |
EXHIBIT INDEX
Exhibit |
|
|
Number |
|
|
|
|
|
99.3 |
|
Ciphergen Biosystems, Inc. Press Release issued March 8, 2002. |